Jürgen Frank Schäfer 1
1Division of Pediatric Radiology, Department of Radiology, University Hospital of Tübingen, Tuebingen, Germany
Synopsis
Approximately
10% of children and adolescents with cancer have an underlying CPS. Patients
with CPS have an increased lifetime risk for a specific tumor. In addition to
indications for imaging in cases of clinical suspicion, planned screenings to
exclude clinical occult tumor manifestation are essential. Due to the increased
sensitivity in CPS to ionizing radiation, MRI is favored. WB-MRI employs
fluid-sensitive fat-suppressed 2D sequences as a baseline but must be
supplemented with high-quality organ examination in cases of suspicious
findings or high-risk constellations. With the latest techniques, such as
compressed sensing, the very time-consuming measurements can be considerably
shortened.
Pediatric WBMRI in CPS: Case-Based Learning
Approximately
10% of children and adolescents with cancer have an underlying cancer-predisposition
syndrome (CPS). Common CPS include Li-Fraumeni syndrome, constitutional
mismatch repair deficiency syndrome (CMMRD), hereditary paraganglioma,
phaechromocytoma syndrome, rhabdoid tumor predisposition syndrome, hereditary
retinoblastoma, and neurofibromatosis type1 (NF1). Patients with CPS have an
increased lifetime risk of a specific tumor or of a typical spectrum of
malignancies: for example, brain tumors, osteo- and soft-tissue sarcomas,
adrenocortical carcinomas, and premenopausal breast cancer are more common in
Li-Fraumeni syndrome. Children with hereditary retinoblastoma are more likely
to develop osteosarcomas, soft tissue sarcomas, midface tumors, melanomas, as
well as lung, breast, urinary bladder, uterine cancers. CMMRD is associated
with brain tumors, gastrointestinal and hematologic malignancies. Typical
benign manifestations in NF1 include peripheral nerve sheath tumors (PNST);
malignant neoplasms include malignant PNST (MPNST), visual pathway gliomas, pilocytic
astrocytomas, juvenile myelomonocytic leukemia, and, in middle age, breast
cancer. In addition to indications for imaging in cases of clinical suspicion,
planned screening to exclude clinical occult tumor manifestation is becoming
increasingly important. Typical indications for imaging screening are
asymptomatic children with a proven TDS, a family history of TDS-associated
tumor, or children in whom clinical criteria with an increased risk profile
suggest surveillance is appropriate.
Because of
the increased sensitivity in TDS to ionizing radiation, methods such as
ultrasound and MRI are favored. The type and extent are essentially done by the
risk profile including age and sex. Thus, patients with Li-Fraumeni syndrome
have a nearly 100% cumulative risk of developing one or more cancers with
disease peaking in childhood and in older adults. Because multifocality may
involve other organ systems in addition to the common CNS tumors, a Whole-Body (WB)
MRI examination including a diagnostic CNS MRI is recommended on an annual
basis. In elderly patients who do not require sedation, an additional CNS MRI
should be performed at 6-month intervals, if necessary. In addition, abdominal
sonograms are performed at 3-4 monthly intervals.
WBMRI uses
fluid-sensitive fat-suppressed 2D sequences (STIR) and T1-weighted sequences. The
combination of these two sequences in the context of screening requires a short
examination time, but may need to be supplemented with a higher-quality organ
examination in the presence of suspicious findings or high-risk constellations.
Alternatively,
a one-stage strategy can be pursued with special equipment. In this case, the high
resolution of the WBMRI is aimed for and combined with a targeted examination
(e.g., CNS) or with functional sequences. With the latest techniques, such as
compressed sensing, the measurements, which may be very time-consuming, can be
considerably shortened and thus also performed in awake children. Nevertheless,
it is imperative to develop, harmonize, and evaluate in studies specific
protocols for the different TDS with different risk constellations for the
respective age groups.
Acknowledgements
No acknowledgement found.References
Schäfer JF, Granata C, von Kalle T, et al. Whole-body
magnetic resonance imaging in pediatric oncology - recommendations by the
Oncology Task Force of the ESPR. Pediatric radiology. 2020; 50(8):1162-74
Greer
MC. Imaging of cancer predisposition syndromes. Pediatric radiology. 2018;
48(9):1364-75.
Ballinger ML, Best A, Mai PL, et al. Baseline
Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance
Imaging: A Meta-analysis. JAMA oncology. 2017; 3(12):1634-9.